TY - JOUR
T1 - Correlates of smoking status in cancer survivors
AU - Little, Melissa A.
AU - Klesges, Robert C.
AU - Bursac, Zoran
AU - Halbert, Jennifer P.
AU - Ebbert, Jon
AU - Talcott, Gerald W.
AU - Weksler, Benny
N1 - Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Purpose: To determine the characteristics associated with cancer survivors which indicate continued cigarette smoking at or around the time of cancer diagnosis. Methods: A total of 631 survivors were recruited in four cancer centers in Memphis, TN, between March 2015 and June 2016. To increase the probability of accurate reporting, surveys were conducted anonymously. A total of 112 respondents reported they were current smokers and 202 reported they were former smokers (n = 314), who comprised the sample. Results: We found that the rate of daily e-cigarette use among cancer survivors who smoked was 15.2% versus 3.9% in cancer survivors who no longer smoked. The national rate of adult e-cigarette use is 3.5%. Multivariate models correlated the characteristics of current versus former smokers and revealed that increasing age (aOR = 0.97, p <.0001), decreasing education (aOR = 2.39, p <.02), and current use of e-cigarettes (aOR = 3.74, p <.00045) were frequently associated with current cigarette smoking. Conclusions: While age and gender were associated with continued smoking, current use of e-cigarettes was associated with almost four times higher odds of being a current smoker. Further research is needed to determine if use of e-cigarettes deters or promotes the smoking cessation process, at least in cancer survivors. Implications for Cancer Survivors: Among cancer survivors who continue to smoke after a cancer diagnosis, use of e-cigarettes is highly prevalent; research is needed to determine whether use of e-cigarettes promotes, has no effect, or hinders smoking cessation efforts among this vulnerable population.
AB - Purpose: To determine the characteristics associated with cancer survivors which indicate continued cigarette smoking at or around the time of cancer diagnosis. Methods: A total of 631 survivors were recruited in four cancer centers in Memphis, TN, between March 2015 and June 2016. To increase the probability of accurate reporting, surveys were conducted anonymously. A total of 112 respondents reported they were current smokers and 202 reported they were former smokers (n = 314), who comprised the sample. Results: We found that the rate of daily e-cigarette use among cancer survivors who smoked was 15.2% versus 3.9% in cancer survivors who no longer smoked. The national rate of adult e-cigarette use is 3.5%. Multivariate models correlated the characteristics of current versus former smokers and revealed that increasing age (aOR = 0.97, p <.0001), decreasing education (aOR = 2.39, p <.02), and current use of e-cigarettes (aOR = 3.74, p <.00045) were frequently associated with current cigarette smoking. Conclusions: While age and gender were associated with continued smoking, current use of e-cigarettes was associated with almost four times higher odds of being a current smoker. Further research is needed to determine if use of e-cigarettes deters or promotes the smoking cessation process, at least in cancer survivors. Implications for Cancer Survivors: Among cancer survivors who continue to smoke after a cancer diagnosis, use of e-cigarettes is highly prevalent; research is needed to determine whether use of e-cigarettes promotes, has no effect, or hinders smoking cessation efforts among this vulnerable population.
KW - Cancer survivors who smoke
KW - Smoking cessation
KW - Tobacco use
KW - e-cigarettes
UR - http://www.scopus.com/inward/record.url?scp=85055686689&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055686689&partnerID=8YFLogxK
U2 - 10.1007/s11764-018-0720-x
DO - 10.1007/s11764-018-0720-x
M3 - Article
C2 - 30343442
AN - SCOPUS:85055686689
SN - 1932-2259
VL - 12
SP - 828
EP - 834
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
IS - 6
ER -